| 1/25/2021 |
Global Clinical Diagnostics Market Forecast 2026 |
Wordpress.com |
Bharat Book Bureau Provides the Trending Market Research Report on “Global Clinical Diagnostics Market By Type of Test (Lipid Panel, Metabolic Panel, Complete Blood Count, Infectious Disease Testing, Others), By Product (Instruments, Reagents, Assays and Kits, Software & Services), By Application (Infectious Disease, Cardiovascular, Cancer, Others), By End-User (Diagnostic Laboratory, Hospital & Clinics, Others) By Region, Competition, Forecast & Opportunities, 2026 ” under Diagnostics Category. The report offers a collection of superior ... |
| 1/25/2021 |
Global Clinical Diagnostics Market By Type of Test, By Product, By Application, By End-User By Region, Competition, Forecast & Opportunities, 2026 |
Globe Newswire |
New York, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Clinical Diagnostics Market By Type of Test, By Product, By Application, By End-User By Region, Competition, Forecast & Opportunities, 2026" - https://www.reportlinker.com/p05885388/?utm_source=GNWThe global clinical diagnostics market was valued at around USD 56 billion in 2020 and is expected to grow at a steady CAGR of 8.59% during the forecast period ... |
| 1/24/2021 |
Critical Survey: Luminex (NASDAQ:LMNX) versus Alphatec (NASDAQ:ATEC) |
American Banking News |
... nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market ; FlowSight Imaging Flow cytometer; ImageStream System; CellStream Flow Cytometer; Guava easyCyte line; and Muse Cell Analyzer. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite ... |
| 1/24/2021 |
Critical Survey: Luminex (NASDAQ:LMNX) versus Alphatec (NASDAQ:ATEC) |
rivertonroll.com |
... nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market ; FlowSight Imaging Flow cytometer; ImageStream System; CellStream Flow Cytometer; Guava easyCyte line; and Muse Cell Analyzer. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite ... |
| 1/22/2021 |
Infectious Disease to Dominate Clinical Diagnostics Market During Forecast Period – TechSci Research |
Wordpress.com |
Infectious Disease to Dominate Clinical Diagnostics Market During Forecast Period – TechSci ResearchIncreasing adoption of point of care testing and rising prevalence of COVID-19 is expected to drive growth of global clinical diagnostics marketAccording to TechSci Research report, “ Global Clinical Diagnostics Market By Type of Test (Lipid Panel, Metabolic Panel, Complete Blood Count, Infectious Disease Testing, Others), By Product (Instruments, Reagents, Assays and Kits, Software & Services ... |
| 1/22/2021 |
Infectious Disease to Dominate Clinical Diagnostics Market During Forecast Period |
techsciblog.com |
Home Healthcare Infectious Disease to Dominate Clinical Diagnostics Market During Forecast Period Infectious Disease to Dominate Clinical Diagnostics Market During Forecast Period By TechSci Research Healthcare 0 CommentsIncreasing adoption of point of care testing and rising prevalence of COVID-19 is expected to drive growth of global clinical diagnostics marketAccording to TechSci Research report, “ Global Clinical Diagnostics Market By Type of Test (Lipid Panel, Metabolic Panel, Complete ... |
| 12/16/2020 |
Attana completes FDA Medical Device Class 1 listing and facility registration |
cision.com |
... and Drug Administration (FDA).The facility registration and listing of Attana Cell™ 250 as a Class I device (510(k) exempt) are the first regulatory requirements for marketing Attana’s instruments towards the clinical diagnostics market . In 2021, Attana intends to complement these by filing for an FDA approval of at least one complementary assay as a Class II device, subject to 510(k) clearance. Simultaneous to these efforts ... |
| 9/7/2020 |
2020-2029 Report on Global Clinical Mass Spectrometry Market by Player, Region, Type, Application and Sales Channel |
reportsnreports.com |
... perspectives in the Clinical Mass Spectrometry market. Leading players of Clinical Mass Spectrometry including: - Thermo Fisher Market split by Type, can be divided into: - LC-MS Market split by Application, can be divided into: - Clinical Diagnostics Market split by Sales Channel, can be divided into: - Direct Channel Market segment by Region/Country including: - North America (United States, Canada and Mexico) - Europe (Germany, UK, France, Italy, Russia and Spain etc.) - Asia ... |
| 9/2/2020 |
Global Generic Hematology Analyzers and Reagents Market Size, Status and Forecast 2020-2026 |
reportsmonitor.com |
... the period 2015-2026. The key players covered in this study Abbott Laboratories Danaher Corporation Siemens Bio-Rad Laboratories Roche Sysmex Corporation Nihon Kohden Boule Diagnostics HORIBA BioSystems Diatron Drew Scientific EKF Diagnostics Mindray Ortho Clinical Diagnostics Market segment by Type, the product can be split into Generic Hematology Analyzers Generic Hematology Reagents Market segment by Application, split into Hospital Clinic Laboratory Other Market segment by Regions/Countries, this report covers ... |
| 8/27/2020 |
SQI Diagnostics Inc. Announces Stock Option Grant |
PR Newswire |
... Shares). About SQI Diagnostics SQI Diagnostics is a life sciences and diagnostics company that develops clinical grade multiplexed microarray and molecular assays run on its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics market s. SQI develops custom research and diagnostic assays that are multiplexed; meaning the simplification, consolidation and automation of many individual tests into one. This increases sample throughput, reduces time, cost and chance for human ... |
| 8/27/2020 |
SQI Diagnostics Reports Third Quarter 2020 Results |
PR Newswire |
... protected] About SQI Diagnostics SQI Diagnostics is a life sciences and diagnostics company that develops clinical-grade multiplexed microarray and molecular assays run on its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics market s. SQI develops custom research and diagnostic assays that are "multiplexed"; which means many individual tests can now be simplified, consolidated and automated into a single test. This significantly increases sample throughput, reduces time ... |
| 8/18/2020 |
SQI Diagnostics Appoints Rob Chioini as Chief Executive Officer, Grants Options and Amends Stock Option Plan |
PR Newswire |
... meeting. About SQI Diagnostics SQI Diagnostics is a life sciences and diagnostics company that develops clinical grade multiplexed microarray and molecular assays run on its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics market s. SQI develops custom research and diagnostic assays that are multiplexed; meaning the simplification, consolidation and automation of many individual tests into one. This increases sample throughput, reduces time, cost and chance for human ... |
| 8/15/2020 |
$PBIO Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Consumable Device |
traderpower.com |
... markets Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT”) The award of the PCT MicroPestle (“MP”) patent moves Pressure BioSciences even closer to entering the clinical diagnostics market , which is exponentially larger than the research products market where the Company currently transacts business The Company utilizes a “razor: razor blade” business model, and the PCT MP is the Company’s most important ... |
| 8/14/2020 |
Pressure BioSciences, Inc. (PBIO) Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Consumable Device |
Wordpress.com |
... markets Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT”) The award of the PCT MicroPestle (“MP”) patent moves Pressure BioSciences even closer to entering the clinical diagnostics market , which is exponentially larger than the research products market where the Company currently transacts business The Company utilizes a “razor: razor blade” business model, and the PCT MP is the Company’s most important ... |
| 8/14/2020 |
Pressure BioSciences, Inc. (PBIO) Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Consumable Device - QualityStocks |
qualitystocks.com |
... markets Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT”) The award of the PCT MicroPestle (“MP”) patent moves Pressure BioSciences even closer to entering the clinical diagnostics market , which is exponentially larger than the research products market where the Company currently transacts business The Company utilizes a “razor: razor blade” business model, and the PCT MP is the Company’s most important ... |
| 8/14/2020 |
Pressure BioSciences, Inc. (PBIO) Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Con |
livejournal.com |
... markets Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT”) The award of the PCT MicroPestle (“MP”) patent moves Pressure BioSciences even closer to entering the clinical diagnostics market , which is exponentially larger than the research products market where the Company currently transacts business The Company utilizes a “razor: razor blade” business model, and the PCT MP is the Company’s most important ... |
| 8/14/2020 |
Pressure BioSciences, Inc. (PBIO) Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Consumable Device |
blogspot.com |
... markets -Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT”) -The award of the PCT MicroPestle (“MP”) patent moves Pressure BioSciences even closer to entering the clinical diagnostics market , which is exponentially larger than the research products market where the Company currently transacts business -The Company utilizes a “razor: razor blade” business model, and the PCT MP is the Company’s most important ... |
| 8/14/2020 |
Pressure BioSciences, Inc. (PBIO) Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Consumable Device |
blogspot.com |
... markets Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT”) The award of the PCT MicroPestle (“MP”) patent moves Pressure BioSciences even closer to entering the clinical diagnostics market , which is exponentially larger than the research products market where the Company currently transacts business The Company utilizes a “razor: razor blade” business model, and the PCT MP is the Company’s most important ... |
| 8/13/2020 |
Global Protein-based Multiplex Assays Market Size, Status and Forecast 2020-2026 |
reportsmonitor.com |
... BD Abcam Seegene Meso Scale Diagnostics Randox Laboratories Market segment by Type, the product can be split into Reagents & Consumables Instruments & Accessories Software & Services Market segment by Application, split into Companion Diagnostics Research & Development Clinical Diagnostics Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Protein-based Multiplex Assays status ... |
| 8/13/2020 |
Global Nucleic Acid-Based Multiplex Assays Market Size, Status and Forecast 2020-2026 |
reportsmonitor.com |
... BD Abcam Seegene Meso Scale Diagnostics Randox Laboratories Market segment by Type, the product can be split into Reagents & Consumables Instruments & Accessories Software & Services Market segment by Application, split into Companion Diagnostics Research & Development Clinical Diagnostics Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Nucleic Acid-Based Multiplex Assays ... |